Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Can-Fite reports interim analysis data from phase I/II CF-102 trial in liver cancer

May 13, 2011

Novel MEK/ERK inhibitors disclosed by Bayer Schering Pharma

May 13, 2011

Snapshots: Promising preclinical data on ImmunoGen's anticancer agents IMGN-853 and IMGN-529

May 13, 2011

Expression of SCCA serpin B3 as a marker of breast cancer progression

May 13, 2011

Hervix has long-term benefit on recurrence of bladder cancer

May 12, 2011

Talon Therapeutics to begin recruitment in phase III Marqibo trial

May 12, 2011

Duquesne University presents new tamoxifen-melatonin hybrid ligand

May 12, 2011

New anticancer agents prepared by Chinese scientists

May 12, 2011

Swissmedic approves Novartis' Votubia for brain tumors associated with tuberous sclerosis

May 11, 2011

Allos Therapeutics and Mundipharma to codevelop anticancer drug Folotyn

May 11, 2011

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...